Onur Başer

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

Alpesh Amin, Allison Keshishian, Jeffrey Trocio et al. · Current Medical Research and Opinion · 2017 · 71 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study

Kathleen M. Fox, Li Wang, Shravanthi R. Gandra et al. · BMC Cardiovascular Disorders · 2016 · 57 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation

Winnie W. Nelson, Li Wang, Onur Başer et al. · International Journal of Clinical Pharmacy · 2014 · 39 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Prevalence of mastocytosis and Hymenoptera venom allergy in the United States

Charles F. Schuler, Sofija Volertas, Dilawar Khokhar et al. · Journal of Allergy and Clinical Immunology · 2021 · 32 citations · Full text

Life Sciences, Entomology, Immunology +14

Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid Arthritis

Onur Başer, Arijit Ganguli, Sanjoy Roy et al. · Clinical Therapeutics · 2015 · 28 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17